Claudin 6: An Exceptionally Attractive Target for Drug Discovery and Development
July 25, 2022 06:53 ET
|
Research and Markets
Dublin, July 25, 2022 (GLOBE NEWSWIRE) -- The "Claudin 6: A Target Opportunity To Develop Effector-Enhanced Drug Modalities" report has been added to ResearchAndMarkets.com's offering. Claudin 6...
Global Antibody Drug Conjugates Market Report to 2027 - ADC Research and Development is Becoming Increasingly Extensive Around the World
July 13, 2022 04:53 ET
|
Research and Markets
Dublin, July 13, 2022 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market - Forecasts from 2022 to 2027" report has been added to ResearchAndMarkets.com's offering. Antibody Drug...
Global Orphan Cancer Drug Market Report 2022-2028
July 12, 2022 06:48 ET
|
Research and Markets
Dublin, July 12, 2022 (GLOBE NEWSWIRE) -- The "Global Orphan Cancer Drug Market, Drug Sales, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
Global HPAPIs and Cytotoxic Drugs Manufacturing Market Research Report 2022
June 15, 2022 08:13 ET
|
Research and Markets
Dublin, June 15, 2022 (GLOBE NEWSWIRE) -- The "HPAPIs and Cytotoxic Drugs Manufacturing Market, by Drug Origin, by Manufacturing Location, by Drug Type, by Type of Pharmacological Molecule, by...
$5.9 Billion Worldwide Antibody Drug Conjugates Industry to 2031 - Identify Growth Segments for Investment
March 22, 2022 05:28 ET
|
Research and Markets
Dublin, March 22, 2022 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2022: By Type, By Application, By Product, By Technology, By End-User" report has been added to...
Global Cancer Antibody Drug Conjugate Markets, Forecast to 2028 - Sales Trends; Clinical Insights; Dosage, Price & Patent Insights; Quarterly & Yearly Drug Sales; Competitive Landscape and More
March 02, 2022 06:13 ET
|
Research and Markets
Dublin, March 02, 2022 (GLOBE NEWSWIRE) -- The "Global Cancer Antibody Drug Conjugate Market, Drug Sales, Price, & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...
Global Antibody Drug Conjugates Contract Manufacturing Market (2021 to 2028) - Featuring Lonza, Catalent and Siegfried Among Others
November 02, 2021 08:48 ET
|
Research and Markets
Dublin, Nov. 02, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Contract Manufacturing Market Size, Share & Trends Analysis Report By Condition (Myeloma, Lymphoma, Breast Cancer), By...
Global Antibody Drug Conjugates Market Research 2021 Featuring Major Players - Bayer, Concortis Biotherapeutics, F. Hoffman-La Roche, Immunomedics, and Oxford BioTherapeutics
October 20, 2021 09:23 ET
|
Research and Markets
Dublin, Oct. 20, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The...
Insights on the Antibody Drug Conjugates Global Market to 2030 - Featuring 6 Dimensions Capital, AbbVie and ABL Bio Among Others
October 08, 2021 05:58 ET
|
Research and Markets
Dublin, Oct. 08, 2021 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates Market by Indication, Linker, Payload, Target Antigens and Geography: Industry Trends and Global Forecasts, 2021-2030" report...
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
October 06, 2021 07:13 ET
|
Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...